Results 231 to 240 of about 451,388 (320)

Factors Associated With Liver Fibrosis in Patients With Type 2 Diabetes and the Predictive Value of CHI3L1

Portal Hypertension &Cirrhosis, EarlyView.
In a retrospective cohort of 236 patients with type 2 diabetes (T2DM), metabolic dysfunction‐associated steatotic liver disease (MASLD) was common and significant fibrosis (liver stiffness measurement [LSM] ≥8 kPa) was frequently observed. Serum chitinase‐3‐like protein 1 (CHI3L1) correlated with LSM (r = 0.48) and remained an independent predictor of ...
Lixia Sun, Shuangshuang Du, Aili Fan, Jiawen Feng, Fei Wang, Jia Lian, Jie Zhang, Baoxin Qian, Qing Ye   +8 more
wiley   +1 more source

ANGPTL3 and residual atherosclerotic risk: from lipid metabolism to therapeutic targeting. [PDF]

Front Endocrinol (Lausanne)
Weng S, Ding C, Lin J, Chai D.
europepmc   +1 more source

Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease

European Heart Journal, 2017
S. Zewinger, M. Kleber, L. Rohrer, M. Lehmann, S. Triem, Richard T. Jennings, I. Petrakis, A. Dressel, P. Lepper, H. Scharnagl, A. Ritsch, B. Thorand, M. Heier, C. Meisinger, Tonia de las Heras Gala, W. Koenig, S. Wagenpfeil, E. Schwedhelm, R. Böger, U. Laufs, A. von Eckardstein, U. Landmesser, T. Lüscher, D. Fliser, W. März, A. Meinitzer, T. Speer   +26 more
semanticscholar   +1 more source

Modeling of Disease Progression of Type 2 Diabetes Using Real‐World Data: Quantifying Competing Risks of Morbidity and Mortality

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 606-615, March 2025.
ABSTRACT Type 2 diabetes (T2D) is a progressive metabolic disorder that could be an underlying cause of long‐term complications that increase mortality. The assessment of the probability of such events could be essential for mortality risk management. This work aimed to establish a framework for risk predictions of macrovascular complications (MVC) and
Hanna Kunina, Stefan Franzén, Maria C. Kjellsson   +2 more
wiley   +1 more source

Two Sides of Triglycerides in Atherogenesis: An Essential Contributor. [PDF]

Clin Med Insights Cardiol
Poznyak AV, Kozlov S, Babayeva GA, Sukhorukov VN, Orekhov AN.   +4 more
europepmc   +1 more source

Baicalin Restores the Hypoglycemic Effect of Metformin by Regulating the Microbial Imidazole Propionate and Short‐Chain Fatty Acids

Phytotherapy Research, EarlyView.
Baicalin restores the hypoglycemic effect of metformin by decreasing the serum imidazole propionate. ABSTRACT Gut microbiota dysbiosis is implicated in metformin non‐response. This study aimed to investigate whether baicalin, a microbiota‐modulating flavonoid derived from Radix Scutellariae, could restore metformin sensitivity and explored the ...
Aiting Wang, Zenghui Miao, Bangrong Huang, Jiayu Zeng, Mingxia Yuan, Dan Yan   +5 more
wiley   +1 more source

Dysfunction of the ABCA1 and ABCG1 Transporters and Their Impact on HDL Metabolism. [PDF]

Antioxidants (Basel)
Laguna-Maldonado KD, Uribe-Ramírez D, Vázquez-Carrada M, Matuz-Mares D, Vilchis-Landeros MM.   +4 more
europepmc   +1 more source

Hepatic fibrosis in patients diagnosed with rheumatoid arthritis and psoriatic arthritis receiving methotrexate: A cross‐sectional analysis using transient elastography

Rheumatology &Autoimmunity, EarlyView.
Hepatic fibrosis and metabolic syndrome are more prevalent in PsA patients treated with methotrexate, compared to RA patients. Metabolic syndrome is associated with the risk of hepatic fibrosis in patients diagnosed with PsA and RA even after adjustment forcumulative methotrexate exposure.
Ratchaya Lertnawapan, Soonthorn Chonprasertsuk, Sith Siramolpiwat, Kanon Jatuworapruk   +3 more
wiley   +1 more source

A Molecularly Imprinted Membrane for High-Density Lipoprotein Extraction in Point-of-Care Testing. [PDF]

Biosensors (Basel)
de Gregorio GL, Prim D, Zavattoni A, Mottini I, Pezzoli D, Roveda F, Pfeifer ME, Segura JM.   +7 more
europepmc   +1 more source

Obstructive sleep apnea and cardiovascular disease in individuals with metabolic dysfunction‐associated fatty liver disease: A prospective cohort study

Sleep Research, EarlyView.
Abstract Objective To assess the association between obstructive sleep apnea (OSA) risk levels and major cardiovascular disease (CVD) subtypes in individuals with metabolic dysfunction‐associated fatty liver disease (MAFLD). Methods This cohort study included 128,022 MAFLD participants from the UK Biobank without CVD at baseline.
Haizhen Chen, Ying Zheng, Hanzhang Wu, Ningjian Wang, Xiao Tan   +4 more
wiley   +1 more source